Intrinsic Imaging Awarded Multi-Center Study for a Novel Vascular Medical Device

Boston, MA / San Antonio, TX — August 13, 2013 — Intrinsic Imaging, an FDA audited, ISO 9001 and ISO 13485 certified imaging core lab specializing in providing imaging core lab services for clinical trials, announced today that it has been awarded a multi-center study for a novel vascular medical device. Throughout this trial, Intrinsic Imaging will provide comprehensive imaging core lab services including specialized radiologic review and analysis of all images.

Intrinsic Imaging's medical device team is led by full-time board-certified, fellowship-trained interventional radiologists all of whom have experience with numerous medical devices in a variety of therapeutic areas, including but not limited to Cardiovascular, Central Nervous System, GI & Genitourinary, Musculoskeletal and Oncology.

Intrinsic Imaging's team has extensive experience in conducting clinical trials focused on the placement, usage, assessment and evaluation of vascular medical devices including catheters, stents, angioplasty balloons, thrombectomy devices, venous access tools as well as novel devices and biologics.

"Intrinsic Imaging has broad experience in radiography (CR and DR), CT, MRI, ultrasound, and 3D reconstruction techniques as they apply to the deployment and surveillance of medical devices," said Amit Mehta, MD, FRCP, Chief Medical Officer, Intrinsic Imaging. "Our combined clinical expertise in utilizing novel medical devices and our in-depth experience in clinical trials bring an unparalleled synergy to sponsors in medical device development."